ARWR - ARROWHEAD PHARMACEUTICALS, INC.
65.1
1.000 1.536%
Share volume: 1,860,581
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$64.10
1.00
0.02%
Summary score
64%
Profitability
47%
Dept financing
41%
Liquidity
50%
Performance
90%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2022 - 2026
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-7.51%
Return on sales
-1128.81%
Return on invested capital
0%
Total debt ratio
63.09%
Debt ratio change over timeo
0%
Current Ratio
5.19%
Quick Ratio
0%
Cash Position Ratio
1.07%
Short-term ratios 2025 - 2026
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
4.58%
Return on sales
-123.33%
Return on invested capital
0%
Total debt ratio
62.42%
Debt ratio change over timeo
0%
Current Ratio
4.56%
Quick Ratio
0%
Cash Position Ratio
0.81%
Last quarter ratios 2026
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
2.56%
Return on sales
15.46%
Return on invested capital
0%
Total debt ratio
64.57%
Debt ratio change over time
0%
Current Ratio
3.38%
Quick Ratio
0%
Cash Position Ratio
0.58%
Performance ratios (change over 4 years) 2022 - 2026
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ARWR | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 10.6% | 11.11% | 0% |
| Return on assets | -7.51% | 4.69% | 3.16% | 1.47% |
| Return on sales | -1128.81% | 30.75% | 25.13% | 22.8% |
| Return on invested capital | 0% | 7.36% | 11.75% | 0% |
| Profitability | 0% | 90% | 87% | 26% |
| Total debt ratio | 63.09% | 80.39% | 59.46% | 95.26% |
| Debt ratio change over time | 0% | -25.01% | -101.26% | 0% |
| Dept financing | 42% | 21% | 16% | 25% |
| Current Ratio | 4.56% | 1.47% | 1.04% | 0.71% |
| Quick Ratio | 0% | 1.14% | 0.77% | 0.59% |
| Cash Position Ratio | 0.81% | 0.18% | 0.36% | 0.14% |
| Liquididy | 50% | 34% | 40% | 28% |
| Short-term ratios | ARWR | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 4.58% | 6.79% | 3.25% | 1.71% |
| Return on sales | -123.33% | 43.13% | 26.46% | 23.71% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 67% | 50% | 27% | 20% |
| Total debt ratio | 62.42% | 79.21% | 59.12% | 101.52% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 40% | 20% | 15% | 25% |
| Current Ratio | 4.56% | 1.47% | 1.04% | 0.71% |
| Quick Ratio | 0% | 1.14% | 0.77% | 0.59% |
| Cash Position Ratio | 0.81% | 0.18% | 0.36% | 0.14% |
| Liquididy | 50% | 39% | 34% | 21% |